Cargando…
Mass spectrometry imaging in gynecological cancers: the best is yet to come
Mass spectrometry imaging (MSI) enables obtaining multidimensional results simultaneously in a single run, including regiospecificity and m/z values corresponding with specific proteins, peptides, lipids, etc. The knowledge obtained in this way allows for a multifaceted analysis of the studied issue...
Autores principales: | Pietkiewicz, Dagmara, Plewa, Szymon, Zaborowski, Mikołaj, Garrett, Timothy J., Matuszewska, Eliza, Kokot, Zenon J., Matysiak, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764543/ https://www.ncbi.nlm.nih.gov/pubmed/36536419 http://dx.doi.org/10.1186/s12935-022-02832-3 |
Ejemplares similares
-
Mass Spectrometry-Based Identification of Bioactive Bee Pollen Proteins: Evaluation of Allergy Risk after Bee Pollen Supplementation
por: Matuszewska, Eliza, et al.
Publicado: (2022) -
Mass spectrometry-based proteomics techniques and their application in ovarian cancer research
por: Swiatly, Agata, et al.
Publicado: (2018) -
Serum Proteomic Profiles of Patients with High and Low Risk of Endometrial Cancer Recurrence
por: Pietkiewicz, Dagmara, et al.
Publicado: (2023) -
Free Amino Acid Alterations in Patients with Gynecological and Breast Cancer: A Review
por: Pietkiewicz, Dagmara, et al.
Publicado: (2021) -
MALDI-MSI—A Step Forward in Overcoming the Diagnostic Challenges in Ovarian Tumors
por: Pietkiewicz, Dagmara, et al.
Publicado: (2020)